Niche partnered closely with DemeRx, a clinical-stage biopharmaceutical company, to support the successful launch of a complex clinical study. From the outset, Niche engaged with DemeRx to understand the unique requirements of their program and rapidly identified a capable clinical site equipped to deliver the study efficiently and in alignment with the protocol’s demands. Beyond site identification and arranging for IMP management, Niche took full ownership of regulatory preparation—developing and coordinating the submission of all required documentation, including ethics and regulatory authority applications. The collaborative, detail-oriented approach ensured the study passed through approval processes smoothly and without unnecessary delays.
Cleothena, a newly established biotech company with a promising innovative medicine in development, has found its progress stalled—not due to scientific limitations, but because of the pressing need for robust, high-quality regulatory documentation.
"During my interactions with Niche I have always been impressed by the standard of the work delivered by the Niche teams. In addition, the contracting process is simple and efficient, communication is open, frequent and proactive, with any issues getting resolved quickly and efficiently. Over the time that I have worked with the Niche team I have found all their representatives to be dedicated, knowledgeable and professional in their approach."
DemeRx, a newly established biotech company with a promising innovative medicine in development found its progress delayed—not due to scientific limitations, but because of the pressing need for identifying a Phase I site the conduct their study and robust, high-quality regulatory documentation for the trial submission. The solution to DemRx’s dilemmas to engage Niche as a service provider known for its agility, strong relationship with most of the UK's Phase I sites and a deep regulatory expertise. Through rapid contracting and seamless onboarding, Niche was able to quickly mobilise a skilled team that immediately grasped the nuances of DemeRx's requirements.
In addition to operational and regulatory support, Niche provided strategic oversight to ensure trial quality and compliance throughout the study lifecycle. This included establishing a clinical monitoring plan, coordinating on-site activities and providing ongoing quality assurance. Responding to a gap in DemeRx’s leadership structure, Niche also assisted in the successful identification and onboarding of an interim Chief Medical Officer, ensuring continuity of medical oversight and regulatory representation. The end-to-end support offered by Niche not only de-risked the study’s start-up phase but also strengthened DemeRx’s clinical infrastructure during a critical stage of development.
When an Alzheimer's programme hit a wall after two negative Phase III trials, EVERSANA called on Niche to make sense of.
read moreNiche partnered with Erytech Pharma to rescue and rewrite substandard clinical study reports, delivering a high-quality.
read moreNiche played a foundational role in securing EMA approval for Strimvelis, the world's first ex vivo autologous gene.
read moreThe clinical evidence Niche helped generate for Funxional's novel anti-inflammatory compound FX125L proved compelling.
read moreNiche prepared the full regulatory package for HOOKIPA's groundbreaking arenavirus immunotherapy platform, enabling the.
read moreWhat began as a CSR writing request grew into a broad regulatory partnership, with Niche guiding iOnctura's roginolisib.
read moreRegulatory documentation, ILAP designation and a robust clinical protocol for the Sunlight Trial — Niche helped.
read moreWorking from poor quality hard copy source materials, Niche rescued and rebuilt Thromboserin's Investigator's Brochure.
read moreFrom Phase I protocols to a full Marketing Authorisation Application, Niche was VectivBio's embedded regulatory writing.
read moreGet our latest news and publications
Sign up to our news letterResources
Social
Contact us
Address
Niche Science & Technology
Unit 26 Falstaff House
Bardolph Road
Richmond TW9 2LH
United Kingdom
